ARTICLE AD BOX
Three recently released Cochrane reviews conclude that GLP-1 medications, such as Ozempic, can lead to meaningful weight loss. However, the findings also highlight concerns about the heavy involvement of drug manufacturers in many of the studies. The World Health Organization (WHO) commissioned the reviews to help shape upcoming global guidelines on using these medications to treat obesity.
The analysis focused on three drugs classified as GLP-1 receptor antag...

1 month ago
30







English (US) ·